Citadel Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Citadel Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-28,100	Closed	-$3.94M	–	10300
2018 Q4	$3.94M	Sell	28,100 -30,300	-52%	-$4.6M	﹤0.01%	3130
2018 Q3	$9.98M	Sell	58,400 -40,300	-41%	-$6.77M	﹤0.01%	2101
2018 Q2	$17.1M	Buy	98,700 +72,100	+271%	+$10.8M	0.01%	1440
2018 Q1	$3.07M	Buy	26,600 +21,500	+422%	+$2.29M	﹤0.01%	3115
2017 Q4	$429K	Sell	5,100 -1,800	-26%	-$150K	﹤0.01%	5888
2017 Q3	$636K	Buy	6,900 +3,000	+77%	+$233K	﹤0.01%	4976
2017 Q2	$313K	Buy	+3,900	New	+$216K	﹤0.01%	5841

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Citadel Advisors's LOXO Position: Q1 2019 in Review

Citadel Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,902 shares — an estimated $686K sold.

Citadel Advisors first reported a position in LOXO in Q4 2015 and held it in 8 quarters. The position peaked at $3.71M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Citadel Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Citadel Advisors sold 4,902 Loxo Oncology, Inc shares in Q1 2019, an estimated $686K.
Citadel Advisors first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 8 quarters.
Citadel Advisors's Loxo Oncology, Inc position peaked at $3.71M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.